Asymptomatic Brain Metastases clinical trials

Explore recruiting asymptomatic brain metastases clinical trials.

Recruiting asymptomatic brain metastases studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Asymptomatic Brain Metastases trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A single arm phase II study evaluating intracranial efficacy of Sacituzumab govitecan (SG) with bevacizumab in patients with asymptomatic brain metastases from non-small cell lung cancer (NSCLC)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Asymptomatic Brain Metastases trials by city

Asymptomatic Brain Metastases clinical trials

Recruiting asymptomatic brain metastases studies right now

Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT

Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer

Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases

Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements

Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

Also recruiting in Europe

A single arm phase II study evaluating intracranial efficacy of Sacituzumab govitecan (SG) with bevacizumab in patients with asymptomatic brain metastases from non-small cell lung cancer (NSCLC)

Asymptomatic Brain Metastases trials by city

Other conditions